You are here

  • Home
  • Online First
  • CALLA: Efficacy and safety of concurrent and adjuvant durvalumab with chemoradiotherapy versus chemoradiotherapy alone in women with locally advanced cervical cancer: a phase III, randomized, double-blind, multicenter study

Citation Tools

Article menu

other Versions

Download PDFPDF

Clinical trial
CALLA: Efficacy and safety of concurrent and adjuvant durvalumab with chemoradiotherapy versus chemoradiotherapy alone in women with locally advanced cervical cancer: a phase III, randomized, double-blind, multicenter study

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Mayadev J, Nunes AT, Li M, et al
CALLA: Efficacy and safety of concurrent and adjuvant durvalumab with chemoradiotherapy versus chemoradiotherapy alone in women with locally advanced cervical cancer: a phase III, randomized, double-blind, multicenter study
International Journal of Gynecologic Cancer Published Online First: 23 May 2020. doi: 10.1136/ijgc-2019-001135